$12.130
-0.050 (-0.41%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
RDY 相似圖表分析預測
Alphio's RDY stock price prediction model matches the current Dr Reddy's Laboratories Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.21 (+0.65%). The 1-week path is $12.42 (+2.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Dr Reddy's Laboratories Ltd 股票嗎?
Dr Reddy's Laboratories Ltd is not a good buy right now due to a recent downgrade from Goldman Sachs, which set a price target of INR 1,075, significantly lower than the current price of $12.18. Additionally, the company's last earnings report showed an EPS of 0.06, which was a 64.71% miss from the expected 0.17, indicating potential ongoing financial struggles. The RSI is currently at 47.072, suggesting the stock is neither overbought nor oversold, but the lack of upward momentum and negative analyst sentiment point to a sell recommendation.
RDY 股價於 Monday 收在 $12.13,此前下跌 -0.41%
Dr Reddy's Laboratories Ltd (RDY) last closed at $12.13, losing -0.41%. These facts feed the 1-day and 1-week RDY price prediction above.
分析師一致預期
Dr Reddy's Laboratories Ltd(RDY):買進 0、持有 0、賣出 1。展望:Strong Sell。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Dr Reddy's Laboratories Ltd(RDY)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 RDY 最接近的股票,依相似度排序。
RDY 季節性分析
Historically the probability of a positive September return for RDY is 47.62%. February offers the highest probability of a positive month at 63.79%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。